Answers are grounded in this paper and cite their sources.
Case series finds safety in using etanercept biosimilar for rheumatoid arthritis in pregnancy, suggesting its viability as a treatment option.
Use of the etanercept biosimilar during pregnancy was associated with favourable outcomes, supporting its safety and utility in managing rheumatoid arthritis during pregnancy.
No takes yet. Share an insight, caveat, or question.
Kitada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: